We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$232M
AUM Growth
+$13.2M
(+6%)
Cap. Flow
-$4.67M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
23.57%
Holding
72
New
3
Increased
30
Reduced
34
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$1.93M |
| 2 |
Illinois Tool Works
ITW
|
+$582K |
| 3 |
Bio-Techne
TECH
|
+$369K |
| 4 |
Morgan Stanley
MS
|
+$343K |
| 5 |
Adobe
ADBE
|
+$333K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kimberly-Clark
KMB
|
+$2.07M |
| 2 |
AT&T
T
|
+$932K |
| 3 |
Microsoft
MSFT
|
+$693K |
| 4 |
Home Depot
HD
|
+$484K |
| 5 |
Amazon
AMZN
|
+$459K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.38% |
| 2 | Healthcare | 15.52% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 12.02% |
| 5 | Consumer Discretionary | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Illumina
ILMN
$29B
| $530K | 0.23% |
1,485
+216
| +17% | +$69.2K |
|
|
52
Bio-Techne
TECH
$11.2B
| $426K | 0.18% |
+8,340
| New | +$369K |
|
|
SCHW
53
Charles Schwab
SCHW
$187B
| $418K | 0.18% |
8,501
+1,310
| +18% | +$66.9K |
|
54
Honeywell
HON
$77B
| $414K | 0.18% |
2,753
+422
| +18% | +$59.8K |
|
55
AbbVie
ABBV
$438B
| $404K | 0.17% |
4,272
+616
| +17% | +$58.4K |
|
56
Roper Technologies
ROP
$39.9B
| $395K | 0.17% |
1,332
+207
| +18% | +$61.1K |
|
57
IQVIA
IQV
$39.8B
| $392K | 0.17% |
3,020
+359
| +13% | +$43.1K |
|
|
RTN
58
DELISTED
Raytheon Company
RTN
| $378K | 0.16% |
1,827
+283
| +18% | +$56.3K |
|
59
Bristol-Myers Squibb
BMY
$132B
| $363K | 0.16% |
5,854
+653
| +13% | +$38.8K |
|
|
60
Adobe
ADBE
$109B
| $348K | 0.15% |
+1,290
| New | +$333K |
|
61
Ecolab
ECL
$79.7B
| $341K | 0.15% |
2,172
+343
| +19% | +$50.9K |
|
62
Meta Platforms (Facebook)
META
$1.52T
| $336K | 0.14% |
2,046
+329
| +19% | +$59.6K |
|
63
Chevron
CVX
$382B
| $333K | 0.14% |
2,722
+416
| +18% | +$50.5K |
|
64
Travelers Companies
TRV
$78.3B
| $306K | 0.13% |
2,361
+373
| +19% | +$48.1K |
|
65
Integra LifeSciences
IART
$1.33B
| $300K | 0.13% |
+4,547
| New | +$283K |
|
66
Moody's
MCO
$82.8B
| $299K | 0.13% |
1,790
+296
| +20% | +$52.1K |
|
67
Tesla
TSLA
$1.31T
| $229K | 0.1% |
12,990
+2,145
| +20% | +$44.7K |
|
68
Booking.com
BKNG
$160B
| – | – |
-3,375
| Closed | -$274K |
|
69
Helmerich & Payne
HP
$4.18B
| – | – |
-3,819
| Closed | -$243K |
|
|
70
Kimberly-Clark
KMB
$35.9B
| – | – |
-19,671
| Closed | -$2.07M |
|
|
71
AT&T
T
$165B
| – | – |
-38,429
| Closed | -$932K |
|
72
United Natural Foods
UNFI
$2.8B
| – | – |
-4,847
| Closed | -$207K |
|
Similar funds
NCM
CG
EPCA
WM
BM
EPI
OIM
ECP
Argus Investors Counsel's Q3 2018 Portfolio in Review
As of Q3 2018, Argus Investors Counsel held 72 positions worth $232M, up 6% from $219M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Argus Investors Counsel's Q3 2018 filing shows 3 new, 30 increased, 34 reduced and 5 closed positions. Its largest new stake was Bio-Techne: 8,340 shares worth $426K. The largest sale was Kimberly-Clark, an estimated $2.07M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.
- Argus Investors Counsel's largest Q3 2018 buy was Bio-Techne: 8,340 shares worth $426K.
- Argus Investors Counsel added most to Texas Instruments in Q3 2018, an estimated $1.93M increase.
- Argus Investors Counsel's biggest Q3 2018 reduction was Microsoft, cutting an estimated $693K.
- Argus Investors Counsel fully exited Kimberly-Clark in Q3 2018, selling an estimated $2.07M.
- Argus Investors Counsel's ten largest holdings make up 24% of its $232M portfolio in Q3 2018.
- Argus Investors Counsel opened 3 new positions and closed 5 in Q3 2018.
- Argus Investors Counsel's portfolio value rose 6% quarter-over-quarter to $232M.
Based on Argus Investors Counsel's 13F filing for Q3 2018, filed 16 Oct 2018.